Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction (Q33699818)

28 July 2017

1 reference

title

Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction (English)

1 reference

28 July 2017

main subject

acute coronary syndrome

1 reference

White HD

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

published in

American Heart Journal

1 reference

28 July 2017

volume

138

1 reference

28 July 2017

issue

2 Pt 2

1 reference

28 July 2017

page(s)

S105-14

1 reference

Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Diagnostic efficiency of troponin T measurements in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

The Prognostic Value of Serum Troponin T in Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Prognostic Role of Troponin T Versus Troponin I in Unstable Angina Pectoris for Cardiac Events With Meta-Analysis Comparing Published Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Aspirin, heparin, or both to treat acute unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Inv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(99)70329-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(99)70329-7

1 reference

28 July 2017

1 reference